Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06879041RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This study tests a new radioactive drug, [225Ac]-AZD2284, for men with prostate cancer that has spread and no longer responds to hormone therapy. The drug is designed to target cancer cells and deliver radiation directly to them, potentially slowing the cancer's growth.
Palo Alto, CaliforniaAges 18 years+ - NCT01193088Recruiting
Genetics study for Charcot-Marie-Tooth disease
This study looks at genes linked to Charcot-Marie-Tooth disease (CMT), a condition that affects nerves in the arms and legs. It aims to find new causes and understand why symptoms vary. If you join, you may give a blood or saliva sample for genetic testing.
Los Angeles, CaliforniaAges Any age - NCT06782373RecruitingPhase 2
Pacritinib for VEXAS syndrome
This trial tests whether the drug pacritinib can safely reduce inflammation and improve symptoms in people with VEXAS syndrome, a rare genetic condition that causes inflammation in various parts of the body. It may be a new treatment option for those who still have inflammation despite taking steroids.
Scottsdale, ArizonaAges 18 years+ - NCT07878416Recruiting
Comparing new progressive glasses to standard ones
This study tests a new type of progressive glasses lens, called the Morrow eProgressive, against traditional progressive lenses. It aims to see if the new design helps people with presbyopia (age-related reading vision loss) see better in daily activities.
AntwerpAges 45 years+ - NCT07879170RecruitingPhase 1
Testing a new epilepsy medicine in healthy adults
This study tests a new medicine, EPX-100, for epilepsy in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Tempe, ArizonaAges 18–55 - NCT06466382Recruiting
Personalized cancer therapy for advanced ovarian cancer
This trial tests whether a treatment plan tailored to your specific tumor and health can work better for advanced ovarian, peritoneal, or fallopian tube cancer. It aims to find the best therapy for each patient to improve outcomes.
Baden, Canton of AargauAges 18 years+ - NCT06220773RecruitingPhase 3
combination treatment for type 2 diabetes and high blood pressure
This study tests two new combination medicines for people who have both type 2 diabetes and high blood pressure. It looks at how well they work and how safe they are. Participants stop their current diabetes and blood pressure drugs during the trial, except for the diabetes drug metformin.
Jakarta, DKI JakartaAges 19 years+ - NCT07877948Recruiting
Combination therapy for diabetic nerve pain and foot ulcers
This study tests whether a treatment called Bionerv E+ helps with nerve pain and healing of foot ulcers in people with type 2 diabetes, compared with a standard vitamin B complex. If you have diabetes-related nerve damage and a foot ulcer that is not too severe, this study might help you understand if this new option works.
Cheras, Kuala LumpurAges 18 years+ - NCT07219771RecruitingPhase 3
Knee injection for osteoarthritis pain
This study tests a single injection of PTP-001 (MOTYS™) into the knee to see if it reduces osteoarthritis pain. It is for people whose knee pain is their main pain problem and who haven't found relief from standard pain medicines.
Birmingham, AlabamaAges 40–80 - NCT07326592RecruitingPhase 4
Weekly treatment for emphysema caused by alpha-1 antitrypsin deficiency
This study tests a weekly injection of a protein replacement therapy for adults with emphysema due to alpha-1 antitrypsin deficiency. The goal is to see if this treatment can slow down the loss of lung density over three years.
AalborgAges 18–65 - NCT07878104Recruiting
Ketogenic diet for hard-to-control seizures in adults
This study looks at whether a special high-fat, low-carbohydrate diet can help reduce seizures in adults whose epilepsy has not improved with two or more medications. It is an observational study, meaning participants follow the diet as part of their regular care and the research team tracks their progress.
StockholmAges 18 years+ - NCT07877688Recruiting
Looking for rare disease genes in your DNA
This study will read the DNA (the genetic instructions) of people with rare diseases who do not yet have a diagnosis, to try to find the cause. It may help you get answers about your condition.
GenovaAges birth–17 years - NCT07877051Recruiting
Vapor treatment for heavy menstrual bleeding
This trial tests a new heat-based vapor treatment that removes the lining of the uterus to reduce or stop heavy menstrual bleeding. It may offer an option for women who have not found relief from hormonal treatments and want a non-hormonal approach.
BatumiAges 30–55 - NCT07674277Recruiting
Virtual reality for pain relief in sickle cell crisis
This study tests whether using a virtual reality headset can help reduce pain for adults with sickle cell disease during a painful crisis. The trial aims to see if this non-drug approach can improve comfort while receiving IV pain medication.
Baltimore, MarylandAges 18–88 - NCT07602595Recruiting
Early-life health risks and chronic pain in teens and young adults
This study looks at how early health problems might affect pain that lasts a long time. If you had a muscle or joint surgery, or a rheumatic disease, before age 18, you might help us understand why some people get ongoing pain.
Cincinnati, OhioAges 14–26 - NCT07878767Recruiting
Sound waves for varicose veins in the legs
This study tests a new treatment that uses sound waves to close off varicose veins in the legs, without surgery. It may be an option for people with mild to moderate varicose veins who are looking for a less invasive treatment.
Câmpina, PrahovaAges 35–80 - NCT07878884Recruiting
Light therapy with lung rehab for severe COPD
This trial tests whether adding light therapy to a standard exercise program helps people with severe COPD breathe better and do more in their daily lives. It might be especially helpful if you have advanced COPD and can still walk.
Porto Alegre, Rio Grande do SulAges 18–90 - NCT07877272Recruiting
Better liver testing for high-risk fatty liver disease
This study tests a more detailed way to examine the liver in people with fatty liver disease who also have other health risks. The doctors want to see if this extra testing helps decide whether you need treatment.
MünsterAges 18 years+ - NCT07877519Recruiting
Sedation options for pulsed field ablation in atrial fibrillation
This study compares two ways to keep patients comfortable during a procedure called pulsed field ablation for atrial fibrillation: conscious sedation (you're awake but relaxed) versus general anesthesia (you're fully asleep). The goal is to find which method works better and is safer for patients.
Beijing, Beijing MunicipalityAges 18–80 - NCT07516951RecruitingPhase 2
Study of zampilimab for idiopathic pulmonary fibrosis
This trial tests an investigational drug called zampilimab for people with idiopathic pulmonary fibrosis (IPF). It aims to find a safe and effective dose that may slow lung function decline.
Dothan, AlabamaAges 40 years+ - NCT07678723Recruiting
Pupil test to predict blood pressure drop during C-section
This study checks if a simple pupil light reflex test can predict a drop in blood pressure after spinal anesthesia during elective C-sections. If it works, doctors could better manage blood pressure and reduce dizziness or nausea.
DamiettaAges 18–45 - NCT07783282RecruitingPhase 1
How prostate cancer drugs affect a new medicine
This study looks at how a new medicine called fezolinetant is processed by the body when taken alongside common prostate cancer hormone treatments. It is an early-phase trial that helps researchers understand if there are any drug interactions, which could be important for future treatment options.
Plovdiv, Plovdiv ProvinceAges 50–75 - NCT07218146RecruitingPhase 3
Study of ZL-1310 vs Standard Care for Relapsed Small Cell Lung Cancer
This trial tests a new drug, ZL-1310, against standard treatments for people with small cell lung cancer that has returned after initial therapy. The goal is to see if ZL-1310 works better than other options.
La Jolla, CaliforniaAges 18 years+ - NCT05147701RecruitingPhase 1
Testing stem cell treatment for NAION safety
This Phase 1 study tests whether lab-made stem cells taken from donated umbilical cord are safe for people with NAION. It mainly looks for side effects and safety rather than proving the treatment works.
Naples, FloridaAges Any age
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.